Evidence map›Paper›PMID 42393045›Full record

ArticleNature communications2026

L-type pyocins inhibit the BAM complex to kill without cell entry.

Fabian Munder, Matthew D Johnson, Imogen Samuels, Laura McCaughey, Oleksii Zdorevskyi, Chunxiao Wang, Ashleigh Kropp, Lauren Zavan, Erin P Price, Derek S Sarovich and 10 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Fabian MunderDepartment of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.ORCID 0009-0005-5327-3138
Matthew D Johnson *Centre for Electron Microscopy of Membrane Proteins, Monash Institute of Pharmaceutical Sciences, Parkville, VIC, Australia.
Imogen Samuels *Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, VIC, Australia.
Laura McCaughey *School of Infection and Immunity, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
Oleksii Zdorevskyi *Department of Physics, University of Helsinki, Helsinki, Finland.ORCID 0000-0001-9863-5095
Chunxiao WangDepartment of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, VIC, Australia.
Ashleigh KroppDepartment of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.
Lauren ZavanDepartment of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia.ORCID 0000-0003-4700-3033
Erin P PriceSunshine Coast Health Institute, Birtinya, QLD, Australia.ORCID 0000-0002-1079-4882
Derek S SarovichSunshine Coast Health Institute, Birtinya, QLD, Australia.
Swati VarshneyBio21 Mass Spectrometry and Proteomics Facility, University of Melbourne Bio21 Molecular Science and Biotechnology Institute, Parkville, VIC, Australia.
Christopher A McDevittDepartment of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia.ORCID 0000-0003-1596-4841
Hari VenugopalRamaciotti Centre for Cryo-Electron Microscopy, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.ORCID 0000-0001-5230-2973
Vivek SharmaDepartment of Physics, University of Helsinki, Helsinki, Finland.ORCID 0000-0002-8838-3151
Matthew T DoyleSchool of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Darlington, NSW, Australia.ORCID 0000-0002-1876-1209
Francesca ShortDepartment of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.ORCID 0000-0002-0025-4858
Debnath GhosalCentre for Electron Microscopy of Membrane Proteins, Monash Institute of Pharmaceutical Sciences, Parkville, VIC, Australia.ORCID 0000-0002-2227-0330
James P R ConnollyNewcastle University Biosciences Institute, Newcastle University, Newcastle-upon-Tyne, UK.ORCID 0000-0002-0394-3413
Gavin J KnottDepartment of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.ORCID 0000-0002-9007-6273
Rhys GrinterDepartment of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia. rhys.grinter@monash.edu.ORCID 0000-0002-8195-5348

Funding

Department of Education and Training | Australian Research Council (ARC) DP230102150Department of Health | National Health and Medical Research Council (NHMRC) APP1197376
6 · The paper itself

Abstract

Many antibiotics are ineffective against the Gram-negative pathogen Pseudomonas aeruginosa because of intrinsic defence mechanisms, such as the impermeable bacterial outer membrane. Here, we show that protein antibiotics called L-type pyocins kill P. aeruginosa by inhibiting the β-barrel assembly machinery (BAM) complex at the cell surface, halting outer-membrane protein assembly. Using single-particle cryo-electron microscopy, we show that L-type pyocins bind a surface-exposed region of BamA and deploy a C-terminal peptide that competitively inhibits the BAM complex, demonstrating that cell entry is not required for antibiotic activity. We combine genetics, multi-omics and cryo-electron tomography to show that BAM complex inhibition by L-type pyocins or the cyclic-peptide antibiotic, darobactin, triggers a multifaceted transcriptomic, proteomic, and morphological response. BAM inhibition ultimately leads to a catastrophic loss of membrane integrity and cell death. These results validate BAM as a target for antibiotics that do not enter the cell and define an engineerable system for their development.

Indexed as

Anti-Bacterial AgentsBacterial Outer Membrane ProteinsPseudomonas aeruginosaPyocinsCryoelectron MicroscopyProteomicsAnti-Bacterial AgentsBacterial Outer Membrane ProteinsPyocins

Identifiers

PMID42393045
PMCPMC13463100

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.